Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
139 Results for "
MLL
" in MedChemExpress (MCE) Product Catalog:
Products (139)
139 Results for "MLL" in MCE Product Catalog:
Cat. No.: HY-P701589
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: KMT2D; Trinucleotide Repeat Containing 21; Prev. MLL2; [Histone H3]-Lysine(4) N-Methyltransferase; Prev. TNRC21; Histone-Lysine N-Methyltransferase MLL2; Histone-Lysine N-Methyltransferase 2D; Histone-Lysine N-Methyltransferase 2C; MLL4; Truncated Lysine
Species:
Human
Source:
E. coli
Cat. No.: HY-P701590
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: KMT2D; Trinucleotide Repeat Containing 21; Prev. MLL2; [Histone H3]-Lysine(4) N-Methyltransferase; Prev. TNRC21; Histone-Lysine N-Methyltransferase MLL2; Histone-Lysine N-Methyltransferase 2D; Histone-Lysine N-Methyltransferase 2C; MLL4; Truncated Lysine
Species:
Human
Source:
E. coli
Cat. No.: HY-P702887
Purity: ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: KMT2C; Homologous To ALR Protein; Prev. MLL3; Myeloid/Lymphoid Or Mixed-Lineage Leukemia 3; Histone-Lysine N-Methyltransferase 2C; [Histone H3]-Lysine(4) N-Methyltransferase; HALR; Histone-Lysine N-Methyltransferase MLL3; KIAA1506; Lysine N-Methyltransfer
Species:
Human
Source:
E. coli
Cat. No.: HY-175802
CAS No.: 2982574-79-6
Synonyms: HYBI-084
Target:
Research Areas:
HBI-2375 (HYBI-084) is a brain-penetrant WDR5 inhibitor with an IC50 of 4.48 nM. HBI-2375 binds to the WINR5 and disrupts MLL1-WDR5 protein-protein interactions. HBI-2375 inhibits cancer cells proliferation and shows anti-tumor activity in AML mouse models, and increases tumor CD8 + cytotoxic T lymphocyte infiltration. HBI-2375 inhibits hERG with an IC50 of 17 µM .
Cat. No.: HY-134921
CAS No.: 1934302-23-4
Target:
Research Areas:
MI-nc dihydrochloride is a weak inhibitor of the Menin-MLL fusion protein interaction with an IC50 of 193 μM. MI-nc dihydrochloride can be used as a negative control compound of MI-2 .
Cat. No.: HY-132001A
CAS No.: 2134675-92-4
Synonyms: (R)-KO-539
Target:
Research Areas:
(R)-Ziftomenib ((R)-KO-539) is the R-enantiomer of Ziftomenib (HY-132001). Ziftomenib (KO-539) is an orally active menin-MLL interaction inhibitor with antitumor activities .
Target:
Research Areas:
AS-85 is a potent ASH1L histone methyltransferase inhibitor (IC50=0.6 μM) with anti-leukemic activity. AS-85 strongly binds to the ASH1L SET domain, with the Kd value of 0.78 μM .
Cat. No.: HY-164456
CAS No.: 78866-14-5
Target:
Research Areas:
AMI-408 is a PRMT1 inhibitor. AMI-408 can reduce H4R3me2as level in MLL-GAS7 leukemia cells .
Cat. No.: HY-RS07401
Target:
Research Areas:
KMT2A Human Pre-designed siRNA Set A contains three designed siRNAs for KMT2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-184342
CAS No.: 3137103-02-4
Target:
Research Areas:
SYC-2863 is a CRBN-recruiting PROTAC degrader that selectively degrades ENL (MLLT1), with an ENL DC50 of 45 nM in MV4;11 cells. SYC-2863 inhibits the proliferation of MLL-rearranged leukemia and multiple myeloma cells. After degrading intracellular ENL, SYC-2863 dose-dependently downregulates the transcription levels of MYC and its downstream target genes, blocking the MYC-mediated malignant proliferation pathway. SYC-2863 can be used in studies related to MLL-rearranged leukemia and multiple myeloma .
Cat. No.: HY-132001S
Synonyms: KO-539-d3
Cat. No.: HY-132001S1
Synonyms: KO-539-d4
Cat. No.: HY-117365
CAS No.: 1887178-64-4
Target:
Research Areas:
MI-1481 is a highly potent inhibitor of the Menin-MLL1 interaction with IC50 of 3.6 nM. MI-1481 markedly reduces cell growth of murine bone marrow cells transformed and inhibits leukemia progression .
Cat. No.: HY-P703634
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: KMT2C; Homologous To ALR Protein; Prev. MLL3; Myeloid/Lymphoid Or Mixed-Lineage Leukemia 3; Histone-Lysine N-Methyltransferase 2C; [Histone H3]-Lysine(4) N-Methyltransferase; HALR; Histone-Lysine N-Methyltransferase MLL3; KIAA1506; Lysine N-Methyltransfer
Species:
Human
Source:
E. coli
Cat. No.: HY-114162R
CAS No.: 2169916-18-9
Synonyms: SNDX-50469 (Standard)
Research Areas:
VTP50469 (Standard) is the analytical standard of VTP50469. This product is intended for research and analytical applications. VTP50469 is a potent, highly selective and orally active Menin-MLL interaction inhibitor with a Ki of 104 pM. VTP50469 has potently anti-leukemia activity .
Synonyms: DSP-5336
Target:
Research Areas:
Enzomenib (DSP-5336) is an orally active Menin inhibitor (IC50=1.4 nM, Kd=6.0 nM). Enzomenib disrupts the interaction between Menin and KMT2A/MLL fusion proteins, specifically inhibits the expression of leukemia driver genes such as HOX/MEIS1, and upregulates ITGAM. Enzomenib effectively induces cell differentiation, inhibits tumor cell proliferation, and suppresses primitive cell colony formation. Enzomenib reduces disease burden and prolongs survival, but causes adverse reactions including differentiation syndrome and QTc interval prolongation. Enzomenib is used for research on relapsed/refractory acute myeloid leukemia, acute lymphoblastic leukemia, and other hematologic malignancies with mixed lineage leukemia (MLL) rearrangements or NPM1 mutations .
Cat. No.: HY-183354
Research Areas:
HLC40 is a MLL1 histone methyltransferase inhibitor with an IC50 of 0.82 μM by binding to WDR5. HLC40 inhibits proliferation of cancer cells, induces apoptosis and upregulates cleaved caspase-3 levels. HLC40 exhibits antitumor efficacy in a murine AML xenograft model .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
